Abstract
Background: This study sought to evaluate gender and APOE genotype-related differences in the concentrations of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) and cerebrovascular injury across the life span of cognitively normal adults. Methods: CSF amyloid beta1-42 (Aβ42), phospho-Tau-181 (p-Tau181), and total tau were measured in 331 participants who were between the ages of 21 and 100. CSF E-selectin and vascular cell adhesion protein 1 (VCAM1) were measured in 249 participants who were between the ages of 50 and 100. Results: CSF total tau and p-Tau181 increased with age over the adult life span (p < 0.01) with no gender differences in those increases. CSF Aβ42 concentration varied according to age, gender, and APOE genotype (interaction of age × gender × ϵ4, p = 0.047). CSF VCAM1, but not E-selectin, increased with age (p < 0.01), but both were elevated in men compared to women (p < 0.01). Conclusions: Female APOE-ϵ4 carriers appear at higher risk for AD after age 50. In contrast, men may experience a relatively higher rate of cerebrovascular injury in middle and early old age.
Original language | English (US) |
---|---|
Article number | 48 |
Journal | Alzheimer's Research and Therapy |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - Jul 3 2017 |
Keywords
- APOE genotype
- Age
- Alzheimer's disease
- Biomarkers
- Cerebrospinal fluid
- Cerebrovascular disease
- Gender
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
- Cognitive Neuroscience